64th American Society of Hematology (ASH) Annual Meeting and Exposition
Analysis Of Adverse Events Following Rusfertide Dosing In REVIVE: A Phase 2 Study In Patients With Polycythemia Vera (Oral Presentation)
Pemmaraju N, et al
Subgroup Analysis Of Adverse Events Following Rusfertide Dosing In REVIVE: A Phase 2 Study In Patients With Polycythemia Vera (Poster)
Pemmaraju N, et al
VERIFY: A Phase 3 Study Of The Hepcidin Mimetic Rusfertide (PTG-300) In Patients With Polycythemia Vera (Oral Presentation)
Verstovsek S, et al
VERIFY: A Phase 3 Study Of The Hepcidin Mimetic Rusfertide (PTG-300) In Patients With Polycythemia Vera (Poster)
Verstovsek S, et al